Introduction：Basic information about CAS 158318-63-9|Bectumomab, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Bectumomab |
|---|
| CAS Number | 158318-63-9 | Molecular Weight | / |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | / | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
Bectumomab BiologicalActivity
| Description | Bectumomab (IMMU-LL 2) is an humanized IgG2a mAb against human CD22 (antigen). Bectumomab is also an anti-lymphoma antibody fragment. Bectumomab can be used for imaging in combination with technetium 99 (Tc99m LL2 Fab). Moreover, Bectumomab examines in the staging of recurrent or newly diagnosed non-Hodgkin's lymphoma (NHL) and to assess targeting before radioimmunotherapy (RIT)[1]. |
|---|
| Related Catalog | Research Areas >>CancerSignaling Pathways >>Others >>Others |
|---|
| Target | CD22[1] |
|---|
| In Vitro | Bectumomab 可与小鼠单克隆免疫球蛋白 LL-2 轻链二硫化形成二聚体[1]。 |
|---|
| References | [1]. Lamonica D, et al. Radioimmunoscintigraphy (RIS) with bectumomab (Tc99m labeled IMMU-LL2, Lymphoscan) in the assessment of recurrent non-Hodgkin's lymphoma (NHL). Cancer Biother Radiopharm. 2002 Dec;17(6):689-97. |
|---|
Chemical & Physical Properties
| No Any Chemical & Physical Properties |
